P88-DIY Dietary Antigen Test (IgG and IgG4 Food Antibody Panel)

The P88-DIY Dietary Antigen Test measures immunoglobulin G and the IgG4 subclass directed against 88 dietary antigens from a blood spot specimen. It is ordered in functional and integrative practice by practitioners investigating patients with bloating, altered bowel habit, fatigue, headache, skin complaints, or joint symptoms attributed to food, typically with the intention of identifying foods to eliminate from the diet. Practitioners should understand what food-specific IgG represents before interpreting a result. IgG against dietary protein is produced following normal antigen exposure across the intestinal mucosa, and its presence indicates that the immune system has encountered the food and responded conventionally. Titres correlate with how frequently and how much of a food is eaten, so elevated IgG to staple foods is the expected finding in a healthy person, and food-specific IgG is readily detectable in asymptomatic individuals. The IgG4 subclass carries a more specific meaning that compounds the difficulty: IgG4 is a blocking, anti-inflammatory antibody that rises with sustained antigen exposure and is the antibody that increases during successful allergen immunotherapy, where its appearance accompanies the development of clinical tolerance. Interpreting elevated IgG4 as evidence of sensitivity therefore runs directly counter to the established understanding of what that antibody signifies. This is reflected in an unusually consistent professional position. The American Academy of Allergy, Asthma and Immunology, the European Academy of Allergy and Clinical Immunology, and the corresponding Canadian and Australasian societies have all published statements advising against food-specific IgG testing for the diagnosis of food intolerance, and the test appears in Choosing Wisely recommendations as one to avoid. The concerns raised are practical as well as theoretical. Panels of this breadth commonly flag twenty to forty foods, and acting on such results produces extensive elimination diets that carry a risk of nutritional inadequacy and may reinforce disordered eating patterns, particularly in patients already anxious about food. There is also a risk of diagnostic delay: bloating, altered bowel habit, and fatigue are the presenting features of coeliac disease, inflammatory bowel disease, and enteric infection, all of which have validated tests and established treatment, and all of which warrant exclusion before symptoms are attributed to food antibodies. Genuine adverse food reactions are real and deserve proper investigation, but through validated routes: specific IgE testing or skin prick testing for suspected IgE-mediated allergy, coeliac serology for gluten-related symptoms, hydrogen or methane breath testing for lactose or fructose malabsorption, and a structured elimination and supervised reintroduction protocol — ideally with dietetic support — which remains the reference approach for identifying food triggers in functional gastrointestinal disorders. This panel should not substitute for those investigations, and its results should not be used to direct dietary restriction.